. Although emerging data demonstrate that obesity is a risk factor for infectious diseases, no study has investigated the relationship of bariatric surgery with the risk of infectious diseases among obese adults.
effective method to achieve substantial and persistent weight loss for morbidly obese patients, as supported by a body of evidence [12, 13] and the national guidelines [14] . Accordingly, epidemiological investigations have utilized a self-controlled case series analysis using bariatric surgery as an instrument for examining the effect of weight reduction on various health conditions (eg, heart failure, asthma) [15] [16] [17] .
In this context, we used large population-based databases to examine the effectiveness of bariatric surgery on infectious disease-related outcomes. Specifically, we tested the hypothesis that bariatric surgery is associated with a decrease in the risk of emergency department (ED) visit or hospitalization for 4 common infectious diseases: SSTI, respiratory infections, intraabdominal infections, and UTI.
METHODS

Study Design and Setting
We conducted a self-controlled case series study using population-based data from the Healthcare Cost and Utilization Project (HCUP) State Emergency Department Databases (SEDD) and State Inpatient Databases (SID) of 3 US states (California, Florida, and Nebraska) from 1 January 2005 through 31 December 2011. The details of the study design, SEDD and SID databases, study setting, population, measurements, and statistical analyses may be found in the Supplementary Methods. In brief, the self-controlled case series study design involves intraperson comparisons in a population of subjects with both the exposure (bariatric surgery) and outcome of interest (ED visit and/or hospitalization for infectious diseases) [15, 16] . Because this study design allows each person to function as his or her own control, no separate control subjects are needed. Furthermore, the major advantage of this design is that the effects of any time-invariant covariates (eg, patient characteristics) are implicitly controlled, thereby minimizing unmeasured confounding [18] . In this study, we compared each patient's risk of an ED visit or hospitalization for infectious disease during a 4-year period (ie, 2-year period before and 2-year period after bariatric surgery).
The SEDD captures all treat-and-release and transfer ED visits from short-term, acute-care, nonfederal hospitals in participating states. The SID captures all inpatient discharges from short-term, acute-care, nonfederal, general, and other specialty hospitals. Taken together, we identified all ED visits regardless of disposition and all hospitalizations regardless of source. These 3 states were selected for their high data quality and mainly because their data included unique encrypted patient identifiers that enable follow-up of specific patients across years. The institutional review board of Massachusetts General Hospital approved this study.
Study Population
We included adults aged 18- [14] , we excluded patients aged >65 years. We also excluded out-of-state residents, patients who had multiple bariatric surgeries during the study period, and those who died at hospitalization for bariatric surgery.
Measurements and Outcome Measures
The outcome measures of interest were an ED visit or hospitalization for 4 common infectious diseases: SSTI, respiratory infection (including upper respiratory infection and pneumonia), intra-abdominal infection (including hepatobiliary and enteric infections) except for gynecological infection, and UTI. These infectious diseases were defined by the ICD-9-CM codes based on the literature (Supplementary Table 1 ) [6, 19] . These 4 infectious diseases account for approximately 70% of hospitalizations for infectious diseases in the United States [19] . Moreover, SSTI, respiratory infection, and UTI were the most frequent reasons for ED visit among patients aged 15-64 years [20] .
Statistical Analysis
First, to compare each patient's risk of outcomes (overall and 4 infectious diseases individually), we fitted conditional logistic regression models to calculate odds ratios (ORs)-with presurgery months 13-24 as the reference period-for presurgery months 1-12, postsurgery months 0-12, and postsurgery months 13-24. Because each patient was matched to his/her own reference period, ORs from the conditional logistic regression model are equivalent to having person fixed effects in the model, and hence the estimates are adjusted ORs (aORs). We chose to use 12-month intervals to account for potential seasonal variations that may affect the risk of outcome events [21, 22] . Then, we stratified the analysis by sex as previous studies indicated that the association between obesity and the risk of infectious diseases differs by sex [4] [5] [6] .
We performed a series of sensitivity analyses to examine the consistency of the findings (see details in the Supplementary Methods). In short, we performed the following sensitivity analyses with (1) modeling the outcomes as count variables to compare each patient's incidence of outcomes; (2) stratifying by age group (18-39 and 40-64 years); (3) stratifying by number of comorbidities using Elixhauser comorbidity measures; (4) excluding patients with diagnosis of short-term surgeryrelated infection; (5) stratifying by major bariatric surgery type (Roux-en-Y gastric bypass and gastric banding); (6) stratifying by concurrent prophylactic cholecystectomy; and (7) limiting to the patients who had any ED visits or hospitalizations (regardless of reason) after 24 months from bariatric surgery. Last, we also repeated the analysis using 2 separate populations who underwent an elective nonbariatric surgery (laminectomy or hip replacement) to address the possibility that the changes in infectious disease risks were attributable to any elective surgery, rather than bariatric surgery per se. All analyses were conducted using Stata version 14.1 software (StataCorp, College Station, Texas). A 2-sided P < .05 was considered statistically significant.
RESULTS
We identified 57 040 obese adults who underwent bariatric surgery from 3 state datasets (California, Florida, and Nebraska). Of these, we excluded 695 patients with multiple bariatric surgeries and 68 patients died during the index hospitalization; this left 56 277 patients eligible for analysis. Patient characteristics are shown in Table 1 . The median age was 45 years; most patients were women (79%) and non-Hispanic white (65%).
Overall, 4.3% of adults had an ED visit or hospitalization for any of 4 common infectious diseases during the reference period (Supplementary Table 2 ). Compared to the reference period, the overall risk modestly increased during the first 12 months after bariatric surgery (5.0%; aOR, 1.18 [95% confidence interval {CI}, 1.11-1.25]; P < .001; Table 2 ). Conversely, the risk decreased significantly in the subsequent period of 13-24 months after surgery (3.9%; aOR, 0.91 [95% CI, .86-.97]; P = .002).
Figure 1 depicts the risk of an ED visit or hospitalization for each of 4 infectious diseases by 3-month interval. Compared to the reference period, the risk of SSTI significantly decreased in the first 12-month period after bariatric surgery (aOR, 0.85 [95% CI, .76-.95]; P = .003; Table 2; Figure 1A ) and remained low in the 13-to 24-month postsurgical period (aOR, 0.77 [95% CI, .68-.86]; P < .001). Likewise, the risk of respiratory infection significantly decreased in the first 12-month period after surgery (aOR, 0.82 [95% CI, .75-.90]; P < .001; Table 2 ; Figure 1B ) and remained low in the 13-to 24-month postsurgical period (aOR, 0.75 [95% CI, .68-.82]; P < .001). Similar risk pattern was observed across the subgroups of respiratory infection: upper respiratory infection and pneumonia (Table 2) . By contrast, the risk of intra-abdominal infection and UTI significantly increased in the first 12-month period after bariatric surgery and remained high in the 13-to 24-month postsurgical period (all P < .01; Table 2 ; Figure 1C and 1D) . Notably, the risk of hepatobiliary infection significantly increased after surgery (aOR for the risk during the 0-to 12-month postsurgical period, 5.19 [95% CI, 2.72-9.89], P < .001; aOR for the risk during the 13-to 24-month postsurgical period, 4.18; [95% CI, 2.17-8.08]).
The overall risk pattern of 4 common infectious diseases differed by sex (Supplementary Table 3 ). In men, the overall risk decreased significantly during the 13-to 24-month postsurgical period (aOR, 0.69 [95% CI, .60-.79]; P < .001). By contrast, in women, the risk increased modestly in the first 12-month postsurgical period (aOR, 1.24 [95% CI, 1.17-1.33]; P < .001) and returned to the baseline risk thereafter (aOR, 0.97 [95% CI, .91-1.04]; P = .43). Figure 2 depicts the risk of the 4 common infectious diseases with stratification by sex. Similar to the overall results, the risk of SSTI and respiratory infections varied by sex during the 2-year period after bariatric surgery (Supplementary  Table 3 ; Figure 2A and 2B), with greater effect sizes observed in men. In contrast, the risk of intra-abdominal infection and UTI increased after bariatric surgery, particularly in women (Supplementary Table 3 ; Figure 2C and 2D). For example, while men had no significant change in the risk for UTI during the 0-to 12-month and 13-to 24-month postsurgical periods (both P > .10), women had a significantly higher risk of UTI both in the 0-to 12-month and 13-to 24-month postsurgical periods (both P < .001).
In the sensitivity analyses, the temporal patterns in the risk of infectious diseases were similar with modeling the outcome as a count variable (Supplementary Table 9 ). Additionally, in a subgroup analysis that included only patients known to be alive until at least 2 years after bariatric surgery, the risk patterns of 4 common infectious diseases were essentially unchanged (Supplementary  Table 10 ). Furthermore, in the separate self-controlled analyses using obese adults who underwent laminectomy (n = 16 381) or hip replacement (n = 9401), the risk of SSTI or respiratory infection did not decrease after nonbariatric surgeries (Supplementary Table 11 ). Likewise, the risk of intra-abdominal infection and UTI did not decrease in this population.
DISCUSSION
In this self-controlled case series study using population-based data of 56 277 obese adults from 3 US states, we found that bariatric surgery had a divergent association with risk for ED visits and hospitalizations for 4 common infectious diseases. We found a decreased risk of SSTI and respiratory infection after bariatric surgery, whereas there were no significant decreases in the risk for infectious diseases after elective nonbariatric surgery (ie, laminectomy and hip replacement). In contrast to the decrease in risk of SSTI and respiratory infections, the risk of intra-abdominal infection and UTI increased after bariatric surgery. Additionally, there was heterogeneity in the risk patterns between men and women-for example, men had no significant change in the risk of UTI whereas women had a significant increase in the risk of UTI after bariatric surgery. Recent cohort studies have reported the association between obesity and the risk of infectious diseases. A Danish study of 37 808 participants reported that, compared to normal weight, obesity was associated with increased risks of hospital-based treatment (hospitalization and hospital-based outpatient care) for infectious diseases, such as SSTI in men and respiratory infection in women [6] . Similarly, another cohort study of 75 001 Danish women also reported that, compared to normal weight, obesity was associated with increased risks of erysipelas and upper respiratory infection [7] . Another prospective cohort study of 48 551 participants also reported that morbid obesity is associated with higher risks of pneumonia in men [5] . These emerging data collectively indicate that obesity is an important (and potentially modifiable) risk factor for infectious diseases. In this context, our study investigated, for the first time, the relationship of bariatric surgery (and large weight reduction by using bariatric surgery as an instrument) with the risk of infectious diseases. The validity of our findings is supported by the self-controlled case series study design in which each patient functions as a control for him/herself, thereby reducing the intraperson variations and unmeasured confounding that can occur with traditional cohort and case-control studies [18] . Taken together, the current findings support the hypothesis that bariatric surgery can lower the risk of infectious diseases.
To confirm the causal relationship of bariatric surgery on the risk of infectious diseases, randomized controlled trials of surgical weight-reduction intervention in morbidly obese patients are essential. However, such trials are logistically and methodologically difficult [15, 16] . Additionally, patients who consent and participate in a randomized controlled trial may be systematically different from the general populations [23] . By contrast, our analysis of a large population-based dataset demonstrates an association of bariatric surgery and risk of infectious diseases in a real-world setting and hence augments the potential generalizability of the findings.
The mechanisms that underlie the observed association of bariatric surgery with the decreased risk of SSTI and respiratory infection warrant clarification. Plausible explanations include anatomical changes and improvement of immune systems achieved by a weight reduction. For example, improvement of blood perfusion to (and venous return from) the peripheral tissues and decreases of skin folds may reduce the risk of SSTI [24] . Additionally, bariatric surgery and weight reduction may reverse the obesity-associated restrictive ventilatory pattern and the decreased residual volumes that might facilitate airway infections [8] . Furthermore, bariatric surgery also reverses the obesity-related increase in proinflammatory mediator levels [9] and decreases the prevalence of the obesity-related comorbidities (eg, type 2 diabetes) that are known to increase the risk of infectious diseases [10, 11, 25] .
In contrast, we found that the risk of intra-abdominal infection increased after bariatric surgery. The increased risk was driven by the increased risk of both enteric infection and hepatobiliary infection. The literature also reported an increased risk of cholecystitis due to supersaturation of bile with cholesterol during weight loss (regardless of surgical or nonsurgical intervention) [26] . In addition to the bariatric surgery-related weight reduction and metabolic alterations, the increased risk of hepatobiliary infections may also be attributable to anatomical changes given our finding that the risk of hepatobiliary infection increased in both procedural groups (Roux-en-Y gastric bypass and gastric banding), with a larger effect size in the former group. Any combination of these factors explains, at least in part, the observed findings.
Interestingly, the increased risk of UTI after bariatric surgery was observed only in women. The possible reasons for this finding are likely multifactorial: weight reduction-induced changes in sex hormones (eg, decrease in estrogen level) [27] that have beneficial effects on the urinary tract [28] , a higher frequency of sexual intercourse in lean women compared with obese women [29] , and loss of adipose tissue that is protective for the female genital membranes against intercourse [30] . Although the literature has suggested that obesity is a risk factor for UTI in men, there is a controversy regarding the relationship in women [4, 31, 32] . Our observations should promote further studies to clarify the relationship of obesity and weight reduction with the risk of UTI in women.
This study has several potential limitations. First, as with other studies using administrative data, misclassification of healthcare utilization is possible. Nevertheless, the HCUP data are rigorously tested, and widely used to estimate diagnoses and ED visit/hospitalization frequency [33, 34] . Additionally, as potential misclassifications are less likely to vary substantially between pre-and postsurgery periods, any potential misclassifications are unlikely to have affected our inferences materially. Second, the SEDD and SID did not include information on patients' weight or body mass index (BMI). However, it is well documented in the literature that bariatric surgery achieves a substantial, rapid, and sustained weight reduction [13] . Bariatric surgery decreases 11-14 kg/m 2 of BMI after a year in patients with morbid obesity, and the weight loss persists for the next 2-3 years [13] . Furthermore, 97% of patients who underwent Roux-en-Y gastric bypass did not regain weight back to their baseline weight for 10 years [35] . The current study demonstrated sustained decreases in the risk of SSTI and respiratory infection in parallel to such expected changes in body weight after bariatric surgery. Third, some patients might have been progressively lost to follow-up after their bariatric surgery. While this would have downwardly biased our estimates, we think that this is unlikely because the results were consistent in a subgroup analysis limited to patients known to be alive until at least 2 years after bariatric surgery. Fourth, one may surmise that the observed decreased risk of SSTI and respiratory infection was a consequence of perisurgical intensification of comorbidity management rather than a weight reduction through bariatric surgery per se.
However, a substantial reduction of risk of SSTI and respiratory infection was observed only after bariatric surgery; there was no decrease in the risk of these infectious diseases after an elective nonbariatric surgery in separate obese populations. Fifth, infectious disease events during presurgical periods might have postponed bariatric surgery and potentially biased the inferences. However, the use of 12-month intervals minimizes this bias as the duration of a "clean period" between an infectious disease event and bariatric surgery is less likely to be more than a few months [36] . Finally, the study population was comprised of morbidly obese adults who underwent bariatric surgery. Therefore, our inferences may not be generalizable to overweight or obese patients who are not eligible for bariatric surgery and who attempt weight loss through diet or exercise alone. Nonetheless, our study population contributes to a substantial societal burden [2] .
CONCLUSIONS
In this self-controlled case series analysis of large population-based datasets of obese adults, we found a divergent risk pattern for 4 common infectious diseases after bariatric surgery. The risk of SSTI and respiratory infection decreased after bariatric surgery, whereas risk of intra-abdominal infection and UTI increased. The observed associations were consistent across several different analytic assumptions. For researchers, these findings should promote further investigation into the mechanisms linking obesity and weight reduction to the risk of infectious diseases.
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